COVID-19

News

Altimmune ditches nasal COVID vaccine on weak trial data

Just a few months after starting clinical trials of its nasal spray vaccine for COVID-19, US biotech Altimmune is abandoning the project, saying that it generated weaker than expected immun

News

Mix and match regimen of AZ and Pfizer COVID jabs works well

Giving one dose each of AstraZeneca and Pfizer COVID-19 vaccines provides good protection against the SARS-CoV-2 virus, but may be associated with more adverse reactions, according to new c

News

The unprecedented challenge of pricing a coronavirus vaccine

AZ starts phase 2/3 trial of new-variant COVID-19 vaccine

AstraZeneca and Oxford University have started dosing patients in a trial of a new version of their COVID-19 vaccine that is designed to target the beta or South African variant of the SARS

Views & Analysis

Towards a new understanding of cardiovascular risk in diabetes

Is cardiovascular disease a ‘pandemic hiding in plain sight’...

Amarin’s Craig Granowitz discusses the impact of COVID on cardiovascular disease treatment and explains why there’s still a long way to go till we can truly tackle these diseases.<

News

FDA gives Roche's Actemra emergency okay for severe COVID

Roche has been granted emergency approval by the FDA for its arthritis drug Actemra as a treatment for patients aged two or over who are hospitalised with severe COVOD-19 symptoms.

News